Portfolio company
Euler Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Euler Biologics develops antibody-based therapies to maintain muscle strength and physical function for older adults.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Euler Biologics
Euler Biologics develops antibody-based therapies intended to preserve physical function and support healthy ageing for older adults.
BioAge Labs
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
Immunis Biomedical
Immunis develops stem cell-derived secretome therapeutics to treat age-related muscle atrophy and metabolic dysfunction for patients with sarcopenia and obesity.
Gordian Biotechnology
This company develops an in vivo drug discovery platform to identify therapies for age-related diseases for the pharmaceutical and healthcare sectors.
Cambrian Biopharma
The company develops therapeutics targeting biological drivers of aging and chronic diseases for pharmaceutical partners, healthcare providers and patients.
Juvena Therapeutics
This biotechnology company develops protein-based regenerative medicines for patients with chronic muscle and metabolic diseases.
EpiBiologics
This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.
Abalone Bio
This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.